165 related articles for article (PubMed ID: 38212843)
1. Nanocatalytic Anti-Tumor Immune Regulation.
Li M; Jiang H; Hu P; Shi J
Angew Chem Int Ed Engl; 2024 Mar; 63(13):e202316606. PubMed ID: 38212843
[TBL] [Abstract][Full Text] [Related]
2. Transitional Metal-Based Noncatalytic Medicine for Tumor Therapy.
Wu W; Pu Y; Lu X; Lin H; Shi J
Adv Healthc Mater; 2021 Jun; 10(11):e2001819. PubMed ID: 33857353
[TBL] [Abstract][Full Text] [Related]
3. Nanocatalytic Tumor Therapy by Biomimetic Dual Inorganic Nanozyme-Catalyzed Cascade Reaction.
Gao S; Lin H; Zhang H; Yao H; Chen Y; Shi J
Adv Sci (Weinh); 2019 Feb; 6(3):1801733. PubMed ID: 31168441
[TBL] [Abstract][Full Text] [Related]
4. Ultrasmall Cu
Hu R; Fang Y; Huo M; Yao H; Wang C; Chen Y; Wu R
Biomaterials; 2019 Jun; 206():101-114. PubMed ID: 30927714
[TBL] [Abstract][Full Text] [Related]
5. Dual Size/Charge-Switchable Nanocatalytic Medicine for Deep Tumor Therapy.
Wu W; Pu Y; Shi J
Adv Sci (Weinh); 2021 May; 8(9):2002816. PubMed ID: 33977044
[TBL] [Abstract][Full Text] [Related]
6. Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy.
Qian X; Zhang J; Gu Z; Chen Y
Biomaterials; 2019 Aug; 211():1-13. PubMed ID: 31075521
[TBL] [Abstract][Full Text] [Related]
7. Single-Atom Catalysts for Nanocatalytic Tumor Therapy.
Lu X; Gao S; Lin H; Shi J
Small; 2021 Apr; 17(16):e2004467. PubMed ID: 33448133
[TBL] [Abstract][Full Text] [Related]
8. Nanocatalytic Medicine.
Yang B; Chen Y; Shi J
Adv Mater; 2019 Sep; 31(39):e1901778. PubMed ID: 31328844
[TBL] [Abstract][Full Text] [Related]
9. Nanocatalytic bacteria disintegration reverses immunosuppression of colorectal cancer.
Jiang H; Guo Y; Yu Z; Hu P; Shi J
Natl Sci Rev; 2022 Nov; 9(11):nwac169. PubMed ID: 36381212
[TBL] [Abstract][Full Text] [Related]
10. Bacterial Metabolism-Initiated Nanocatalytic Tumor Immunotherapy.
Wu W; Pu Y; Gao S; Shen Y; Zhou M; Yao H; Shi J
Nanomicro Lett; 2022 Nov; 14(1):220. PubMed ID: 36367591
[TBL] [Abstract][Full Text] [Related]
11. MnOOH-Catalyzed Autoxidation of Glutathione for Reactive Oxygen Species Production and Nanocatalytic Tumor Innate Immunotherapy.
Zhu P; Pu Y; Wang M; Wu W; Qin H; Shi J
J Am Chem Soc; 2023 Mar; 145(10):5803-5815. PubMed ID: 36848658
[TBL] [Abstract][Full Text] [Related]
12. Nanocatalysts-Augmented and Photothermal-Enhanced Tumor-Specific Sequential Nanocatalytic Therapy in Both NIR-I and NIR-II Biowindows.
Feng W; Han X; Wang R; Gao X; Hu P; Yue W; Chen Y; Shi J
Adv Mater; 2019 Feb; 31(5):e1805919. PubMed ID: 30536723
[TBL] [Abstract][Full Text] [Related]
13. Photonic/magnetic hyperthermia-synergistic nanocatalytic cancer therapy enabled by zero-valence iron nanocatalysts.
Dai C; Wang C; Hu R; Lin H; Liu Z; Yu L; Chen Y; Zhang B
Biomaterials; 2019 Oct; 219():119374. PubMed ID: 31369897
[TBL] [Abstract][Full Text] [Related]
14. Mild-temperature responsive nanocatalyst for controlled drug release and enhanced catalytic therapy.
Xu M; Xie X; Liu Y; Topham PD; Zeng Y; Zhan J; Wang L; Yu Q
Acta Biomater; 2023 Sep; 167():473-488. PubMed ID: 37271248
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract][Full Text] [Related]
18. Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
Marofi F; Tahmasebi S; Rahman HS; Kaigorodov D; Markov A; Yumashev AV; Shomali N; Chartrand MS; Pathak Y; Mohammed RN; Jarahian M; Motavalli R; Motavalli Khiavi F
Stem Cell Res Ther; 2021 Mar; 12(1):217. PubMed ID: 33781320
[TBL] [Abstract][Full Text] [Related]
19. The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity.
Wu Z; Li S; Zhu X
Front Immunol; 2021; 12():682435. PubMed ID: 34194437
[TBL] [Abstract][Full Text] [Related]
20. Triggering Sequential Catalytic Fenton Reaction on 2D MXenes for Hyperthermia-Augmented Synergistic Nanocatalytic Cancer Therapy.
Liang R; Li Y; Huo M; Lin H; Chen Y
ACS Appl Mater Interfaces; 2019 Nov; 11(46):42917-42931. PubMed ID: 31635454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
